Traditional Chinese medicine preparation for treating bronchitis

Abstract

The invention discloses a traditional Chinese medicine preparation for treating bronchitis. The traditional Chinese medicine preparation is prepared from the following traditional Chinese medicines in parts by weight: 10-18 parts of sarcandra glabra, 10-15 parts of azalea root, 5-10 parts of psychotria serpens, 15-20 parts of ardisia japonica, 10-15 parts of pygmaeopremna merr., 10-18 parts of rhaphidophora peepla, 12-18 parts of arisaema asperatum, 15-20 parts of radix asparagi, 3-8 parts of amur barberry root, 4-8 parts of bletilla, 8-12 parts of brachystemma edule coll. et hemsl. and 5-10 parts of polygonum cuspidate. The traditional Chinese medicine preparation has the beneficial effects that according to differentiation theory of traditional Chinese medicine, the traditional Chinese medicine preparation is reasonable in compatibility, is simple in composition, is easy in material acquisition, is low in cost and is high in curative effect without toxic or side effects; as having efficacy of relieving cough and asthma, moistening lung, tonifying deficiency, reducing phlegm, invigorating circulation of blood, nourishing yin and clearing heat, the traditional Chinese medicine preparation has curative effect to all patients, is capable of strengthening the foundation and preventing relapse and has total effective ratio reaching up to 99 percent.

Description

technical field [0001] The invention belongs to a traditional Chinese medicine, in particular to a traditional Chinese medicine preparation for treating bronchitis. Background technique [0002] Chronic bronchitis is chronic inflammation of the walls of the trachea and bronchi. The clinical manifestations are cough and sputum that last for more than two consecutive years and last for more than three months every year. The pathology progresses slowly, often with acute attacks, and can develop into chronic obstructive emphysema. This disease is one of common and frequently-occurring diseases in my country, and the prevalence rate in the north of my country is higher than that in the south, and the incidence rate in rural areas is slightly higher than that in cities. The age of onset is more than 40 years old, and the smoking patients are significantly higher than the non-smoking patients. The prevalence of this disease varies greatly due to differences in regions, ages, occ...

AI Technical Summary

Problems solved by technology

At present, the treatment of this disease mainly adopts antibiotics and anti-inflammatory agents, but the root cause of the disease cannot be eliminated, resulting in recurrent attacks and developing into emphysema, which is life-threatening